Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Imidazoles for reversing MDR prepared at Ontogen

Jan. 26, 1998

Clinical results reported for Servier's MDR-reversing agent S-9788

Jan. 23, 1998

Ontogen describes novel MDR modulators

Jan. 23, 1998

Merck & Co. describes FPTase inhibitors with improved pharmacokinetics

Jan. 23, 1998

New telomerase inhibitors from Geron

Jan. 23, 1998

Princeton and Lilly collaborate on development of inhibitors of folate enzymes

Jan. 23, 1998

Gastrimmune significantly increases survival in advanced colorectal cancer

Jan. 22, 1998

Korean researchers characterize new antimicrobial/cytotoxic compound of microbial origin

Jan. 22, 1998

Targon and Duke University form oncology alliance

Jan. 22, 1998

European filing announced for Savedar (DepoCyt)

Jan. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...